High Blood Pressure (Hypertension)References
CitationsJoint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (2003). Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure JNC Express
(NIH Publication No. 03–5233). Bethesda, MD: U.S. Department of Health and
Human Services. Halperin RO, et al. (2006). Dyslipidemia and the risk
of incident hypertension in men. Hypertension, 47(1):
45–50. Rudd P, Osterberg LG (2002). Hypertension: Context,
pathophysiology, and management. In EJ Topol, ed., Textbook of
Cardiovascular Medicine, pp. 91–122. Philadelphia: Lippincott Williams
and Wilkins. Vasan R, et al. (2001). Impact of high-normal blood
pressure on the risk of cardiovascular disease. New England
Journal of Medicine, 345(18): 1291–1297. Nieto F, et al. (2000). Association of
sleep-disordered breathing, sleep apnea, and hypertension in a large,
community-based study. JAMA, 283(14):
1829–1836. Davidson K, et al. (2000). Do depression symptoms
predict early hypertension incidence in young adults in the CARDIA study?
Archives of Internal Medicine, 160(10):
1495–1500. Canadian Hypertension Education Program (CHEP) (2007).
Hypertension: 2007 public recommendations. Available online:
http://www.hypertension.ca/chep/public/publicEducationva.asp. U.S. Preventive Services Task Force, Agency for
Healthcare and Research (2003). Screening for Diabetes
Mellitus, Adult Type 2. Available online:
http://www.ahrq.gov/clinic/uspstf/uspsdiab.htm. Padwal R, et al. (2001). Cardiovascular risk factors
and their effects on the decision to treat hypertension: Evidence-based review.
BMJ, 322(7292): 977–980. Elliott W, et al. (2000). Cost-effectiveness of the
lower treatment goal (of JNC 6) for diabetic hypertensive patients.
Archives of Internal Medicine, 160(9):
1277–1283. Heart Outcomes Prevention
Evaluation Study (HOPE) Investigators (2000). Effects of an angiotensin-converting enzyme
inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine, 342(3): 145–153. Pignone M, Mulrow C (2001). Using cardiovascular risk
profiles to individualise hypertensive treatment. BMJ,
322(7295): 1164–1166. Whelton PK, et al, (2002). Primary prevention of
hypertension: Clinical and public health advisory from the National High Blood
Pressure Education Program. JAMA, 288(15):
1882–188. Douglas JG (2005). Clinical guidelines for the
treatment of hypertension in African Americans. American
Journal of Cardiovascular Drugs, 5(1): 1–6. Flachskampf FA, et al. (2007). Randomized trial of
acupuncture to lower blood pressure. Circulation,
115(24): 3121–3129.
Other Works ConsultedAmerican Heart Association. (2005). Recommendations
for blood pressure measurement in humans and experimental animals. Part 1:
Blood pressure measurement in humans. AHA Scientific Statement. Hypertension, 45(1): 142–161. Appel LJ, et al. (2006). Dietary approaches to prevent
and treat hypertension: A scientific statement from the American Heart
Association. Hypertension, 47(2): 296–308. Campbell N (2003). Hypertension. In J Gray, ed., Therapeutic Choices, 4th ed., pp. 217–238. Ottawa: Canadian Pharmacists Association. Canadian Hypertension Education Program (2007). 2007
Canadian Hypertension Education Program recommendations: The scientific
summary—An annual update. Available online:
http://www.hypertension.ca/chep/en/PublicEducHealtPro.asp. Curhan GC, et al. (2002). Frequency of analgesic use
and risk of hypertension in younger women. Archives of Internal
Medicine, 162(19): 2204–2208. Dahlöf B, et al. (2005). Prevention of cardiovascular
events with an antihypertensive regimen of amlodipine adding perindopril as
required versus atenolol adding bendroflumethiazide as required, in the
Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm
(ASCOT-BPLA): A multicentre randomised controlled trial. Lancet, 366(9489): 895–906. Elliot WJ, et al. (2004). Hypertension: Epidemiology,
pathophysiology, diagnosis, and treatment. In V Fuster et al., eds.,
Hurst's The Heart, 11th ed., vol. 2, pp. 1531–1573. New
York: McGraw-Hill. National Heart, Lung, and Blood Institute (2006).
Your Guide to Lowering Your Blood Pressure With DASH
(NIH Publication No. 06-4082). Available online:
http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf. Schwartz GL, Sheps SG (2004). Hypertension. In DC
Dale, DD Federman, eds., Scientific American Medicine,
section 1, chap 3. New York: WebMD. Sheridan SL, Pignone M (2005). Primary prevention:
Hypertension. Clinical Evidence (14):
151–159. Victor R (2004). Arterial hypertension. In L Goldman,
D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed.,
vol. 1, pp. 346–363. Philadelphia: Saunders.
Go to previous section | Go to top of page | Go to next section |
| | Author: | Carrie Henley Robin Parks, MS | Last Updated: July 30, 2007 | | Medical Review: | Anne C. Poinier, MD - Internal Medicine Caroline S. Rhoads, MD - Internal Medicine Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology Robert A. Kloner, MD, PhD - Cardiology Ruth Schneider, MPH, RD - Diet and Nutrition | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |